Issues and Risks Associated With Handling Antineoplastic Drugs

Abstract

Get full access to this article

View all access options for this article.

References

Falck K. , Grohn P. , Sorsa M. , et al: Mutagenicity in urine of nurses handling cytostatic drugs. Lancet 1:1250-1251,1979

Anderson RW , Puckett WH , Dana WJ , et al: Risk of handling injectable antineoplastic agents. Am J Hosp Pharm 39:1881-1887,1982

Bos RP , Leenaars AO , Theuws Jlg , et al: Mutagenicity of urine from nurses handling cytostatic drugs, influence of smoking. Int Arch Occup Environ Health 50:356-369, 1982

Kolmodin-Hedman B. , Hartvig P. , Sorsa M. , et al: Occupational handling of cytostatic drugs. Arch Toxicol 54:25-33,1983

Nguyen TV , Theiss JC , Matney TS : Exposure of pharmacy personnel to mutagenic antineoplastic drugs. Cancer Res 42:4792-4796, 1982

Staiano N. , Gallelli JF , Adamson RH , et al: Lack of mutagenic activity in urine from hospital pharmacists admixing antitumor drugs. Lancet 1:615-616, 1981

Crudi CB : A compounding dilemma: I've kept the drug sterile but have I contaminated myself. Natl IV Therapy Assoc 3:77-78, 1980

Hemminki K. , Kygronen P. , Lindbohm ML : Spontaneous abortions and malformations in the offspring of nurses exposed to anesthetic gases, cytostatic drugs, and other potential hazards in hospitals, based on registered information of outcome. J Epidemiol Community Health 39:141-147,1985

Knowles RS , Virden TE : Handling of injectable antineoplastic agents. Br Med J 281:589-591,1980

10.

Selevan SG , Lindbohm MJ , Hornung RW , et al: A study of occupational exposure to antineoplastic drugs and fetal loss in nurses. N Engl J Med 313:1173-1178, 1985

11.

Sotaniemi EA , Sutinen S. , Arranto AJ , et al: Liver damage in nurses handling cytostatic agents. Acta Med Scand 214:181-189, 1983

12.

American Society of Hospital Pharmacists: Disposal of unused anticancer drugs. The Signal, May 1979

13.

American Society of Hospital Pharmacists : ASHP technical assistance bulletin on handling cytotoxic and hazardous drugs. Am J Hosp Pharm 47:1033-1049, 1990

14.

Clinical Oncological Society of Australia : Guidelines and recommendations for safe handling of antineoplastic agents. Med J Aust 1:426-428, 1983

15.

AMA Council Report : Guidelines for handling parenteral antineoplastics. JAMA March 15, 1985

16.

Harrison BR : Developing guidelines for working with antineoplastic drugs. Am J Hosp Pharm 38:1686-1693,1981

17.

Hoffman DM : The handling of antineoplastic drugs in a major cancer center. Hosp Pharm 15:302-304,1980

18.

Recommendations for the Safe Handling of Parenteral Antineoplastic Drugs, NIH Publication No. 83-2621. Superintendent of Documents, US Government Printing Office, Washington, DC.

19.

Knowles RS , Virden JE : Handling of injectable antineoplastic agents. Br Med J 281:589-591, 1980

20.

Occupational Safety and Health Administration (OSHA) : Work practice guidelines for personnel dealing with cytotoxic (antineoplastic) drugs. Am J Hosp Pharm 43:1193-1204,1986

21.

Stolar MH , Power LA , Viele CS : Recommendations for handling cytotoxic drugs in hospitals. Am J Hosp Pharm 40:1163-1171,1983

22.

Tortorici MP : Precautions followed by personnel involved with the preparation of parenteral antineoplastic medications. Hosp Pharm 15:293-301, 1980

23.

Zimmerman PF , Larsen RK , Barkley EW , et al: Recommendations for the safe handling of injectable antineoplastic drug products. Am J Hosp Pharm 38:1693-1695, 1981

24.

National Study Commission on Cytotoxic Exposure: Recommendations for Handling Cytotoxic agents, 1987 (available from Louis P. Jeffrey, ScD, Chairman, National Study Commission on Cytotoxic Exposure, Massachusetts College of Pharmacy and Allied Health Sciences, 179 Longwood Ave, Boston, MA 02115)

25.

Harris CC : The carcinogenicity of anticancer drugs: A hazard in man. Cancer 37:1014-1023, 1976

26.

Sieber SM , Adamson RH : Toxicity of antineoplastic agents in man: Chromosomal aberrations, antifertility effects, congenital malformations and carcinogenic potential . Adv Cancer Res 22:57-69,1975

27.

Nicholson HO : Cytotoxic drugs in pregnancy: Review reported cases. J Obstet Gynaecol Br Common 75:307-312, 1968

28.

Reimer RR , Hover R. , Fraumeni JF , et al: Acute leukemia after alkylating agent therapy of ovarian cancer . N Engl J Med 297:177-81, 1977

29.

Rosner F. : Acute leukemia as a delayed consequence of cancer chemotherapy. Cancer 37:1033-1036,1976

30.

Barole A. : Sister-chromatid exchanges in lymphocytes and mutagenicity in urine of nurses handling cytostatic drugs. Mutat Res 157:235-240, 1985

31.

Cloak MM , Connor TH , Stevens KR , et al: Occupational exposure of nursing personnel to antineoplastic agents. Occup Nurs Forum 12:33-39, 1985

32.

Gibson JF , Gompertz D. , Hedworth-Whitty RB : Mutagenicity of urine from nurses handling cytostatic drugs. Lancet 1:100-101, 1984

33.

Newman MA : Biological monitoring for antineoplastic drugs. Doctoral thesis, University of Cincinnati College of Medicine, Cincinnati, OH, 1986

34.

Ratcliffe JM: Occupational exposure to cancerchemotherapeutic agents in pharmacists and nurses, summary report of NIOSH industrywide studies EP:80:41. National

35.

Institute of Occupational Safety and Health, United States Public Health Service, 1983

36.

Rorth M. , Jorgenson V. , Knudsen I. , et al: (Mutagenicitet i urine hos sygeplejersker pa onkologisk afdeling). Danish, Ugeskrift for Laeger 145:475-478, 1983

37.

Stucker I. , Hirsch A. , Dolay T. , et al: Urine mutagenicity, chromosomal abnormalities and sister chromatid exchanges in lymphocytes of nurses handling cytostatic drugs. Int Arch Occup Environ Health 57:195-205,1986

38.

Vernett S. , Crofton-Sleigh C. , Hunt J. , et al: Monitoring of exposure of nursing and pharmacy personnel to cytostatic drugs: Urinary mutation assays and urinary platinum as markers of absorption. Lancet 1:74-77, 1984

39.

Nikula E. , Kivinitly K. , Leistic T. , et al: Chromosome abberations in lymphocytes of nurses handling cytostatic agents. Scan J Work Environ Health 10:71-74, 1984

40.

Norppa H. , Sorsa M. , Vainio H. , Grohn P. , Heinonen E. , Holsti L. , and Norman E. : Increased sister chromatid exchange in frequencies in lymphocytes of nurses handling cytostatic drugs. Scand J Work Environ Health 6:299-301, 1980

41.

Stiller A. , Obe G. , Boll I. , et al: No elevation of the frequencies of chromosomal alternations as a consequence of handling cytostatic drugs. Analysis with peripheral blood and urine of hospital personnel. Mutat Res 121:253-259, 1983

42.

Waksvik H. , Brogger A. , Klepp O. : Chromosome analysis of nurses handling sytostatic drugs. Cancer Treat Rep 65:607-610,1981

43.

Jagun O. , Ryan M. , Wadron HA : Urinary thioether excretion in nurses handling cytotoxic drugs. Lancet 2:443-444, 1982 (letter)

44.

Hirst M. , Mills DG , Tse S. , et al: Occupational exposure to cyclophosphamide. Lancet 1:186-188, 1984

45.

Celio LA , DiGregorio GJ , Ruch E. , et al: Doxorubicin and 5-fluorouracil plasma concentrations and detectability in parotid saliva. Eur J Clin Pharmacol 24:261-266, 1983

46.

Chabner BA : Letter to the editor. N Engl J Med 314:1049, 1986

47.

Mulvihill JJ , Stewart KR : Letter to the editor. N Engl J Med 314:1049,1986

48.

Vaccari PL , Tonat K. , DeChristoforo R. , et al: Disposal of antineoplastic wastes at the National Institutes of Health. Am J Hosp Pharm 41:87-93, 1984